Protalix BioTherapeutics Inc/ US74365A1016 /
| 2024-09-20 9:59:46 PM | Chg. -0.04 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 1.11USD | -3.49% | 5,518 Turnover: 6,275.23 |
-Bid Size: - | -Ask Size: - | 1.16 | 1.10 |
GlobeNewswire
2021-08-02
Enlivex Hires Biotech Industry Veteran Tzvi Palash to Lead the Design and Construction of its New cG...
GlobeNewswire
2021-06-08
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Protalix BioTher...
GlobeNewswire
2021-02-02
Gain Therapeutics Strengthens Leadership Team with the Appointment of Four Industry Leaders to Its B...
GlobeNewswire
2020-10-02
Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce Launch of Expanded Access Program ...
GlobeNewswire
2020-02-20
Galectin Therapeutics Appoints Seasoned Biopharmaceutical Executive Pol F. Boudes, M.D. as Chief Med...
GlobeNewswire
2019-08-30
Protalix BioTherapeutics Receives Listing Deficiency Letter from NYSE American
GlobeNewswire
2019-08-22
Protalix BioTherapeutics Focuses on Evaluating and Pursuing Alternatives to Maximize Shareholder Val...
GlobeNewswire
2019-08-08
Protalix BioTherapeutics Reports Second Quarter 2019 Results and Provides Corporate Update
GlobeNewswire
2019-07-29
Protalix BioTherapeutics to Hold Second Quarter 2019 Financial Results and Corporate Update Conferen...
GlobeNewswire
2019-07-29
Protalix BioTherapeutics Appoints Eyal Rubin as its New Senior Vice President and Chief Financial Of...
GlobeNewswire
2019-07-17
Global Fabry Disease Treatment Market Review 2017-2019 & Forecast to 2025 - Focus on Enzyme Replacem...
GlobeNewswire
2019-06-17
Protalix BioTherapeutics Completes Enrollment in the Phase III BRIGHT Clinical Trial of pegunigalsid...
GlobeNewswire
2019-06-06
Protalix BioTherapeutics and Chiesi Farmaceutici S.p.A to Apply for Accelerated Approval of peguniga...
GlobeNewswire
2019-05-21
Protalix BioTherapeutics Appoints Dror Bashan as its New President and Chief Executive Officer and D...
GlobeNewswire
2019-05-06
Protalix BioTherapeutics Reports 2019 First Quarter Results and Provides Corporate Update
GlobeNewswire
2019-04-29
Protalix BioTherapeutics to Hold First Quarter 2019 Financial Results and Corporate Update Conferenc...
GlobeNewswire
2019-04-12
Research Report Identifies TTM Technologies, Zumiez, Global Net Lease, Catabasis Pharmaceuticals, Bi...
GlobeNewswire
2019-03-18
Protalix BioTherapeutics Reports 2018 Full Year Results and Provides Corporate Update
GlobeNewswire
2019-03-13
Protalix BioTherapeutics to Postpone the 2018 Financial Results and Corporate Update Conference Call
GlobeNewswire
2019-03-06
Protalix BioTherapeutics to Hold Full-Year 2018 Financial Results and Corporate Update Conference Ca...
GlobeNewswire
2019-02-14
Global Fabry Disease Market Insights, Epidemiology and Market Forecast 2019-2028
